Talking Psychedelic Capitalism in a WeWork Ballroom
March 11, 2020
Psychedelic capitalists justify their decision to go for-profit in the ballroom of America’s most recent for-profit flop.
MindMed’s CEO Jamon “JR” Rahn Wants Nothing To Do With Those Psychedelic Decrim People
May 5, 2020
"I want nothing to do with those kinds of folks who want to decriminalize psychedelics,” Rahn told Forbes."
Psychedelic Video Museum Celebrates Virtual Launch
April 24, 2020
Contributors to the Daily Psychedelic Video platform gather on Zoom to bless the opening of the Psychedelic Video Museum: a collection of ten years’ worth of their shared visions.
We Refuse to Endorse Daniel Pinchbeck as a Credible Voice in the Psychedelic Movement
December 5, 2019
Pinchbeck has not publicly engaged in the difficult work of reorganizing his relationship to power, which is a precondition for learning to wield power and authority responsibly. Instead, he has shown that he is predominantly concerned with reestablishing his career and with recentering himself as an authority figure
Third Wave staff quits, writes open letter, over work environment created by founder Paul Austin
March 3, 2019
Eight staff have quit The Third Wave and issued an open statement.
Is Ibogaine the Cure for Opioid Addiction? It’s Not That Simple. | Part 11
January 9, 2018
The Ibogaine Conversation Conclusion | The goal of this conversation was to provide a platform for a diverse range of perspectives on a single topic. Not everyone agrees, and that’s the point.
Talking Ibogaine Research for Opioid Addiction with Thomas Kingsley Brown | Part 5
December 12, 2017
The Ibogaine Conversation Part 5 | Thomas Kingsley Brown, PhD, studied the long-term outcomes of people who received ibogaine for the treatment of opioid addiction. We talked about the results.
Coming Out of the Psychedelic Closet: Final Thoughts
July 6, 2016
Regardless of what conclusions we draw, the topic of psychedelics and identity politics is important at a time when public assumptions about psychedelics are transforming.
Psychedelics and Identity Politics
May 3, 2016
The decades-long “War on Drugs” has created a situation in which the use of psychedelics is a social justice issue.
Comedian Adam Strauss on treating OCD with psilocybin mushrooms
July 21, 2016
Inspired by a scientific study showing that psilocybin mushrooms can potentially cure OCD, Adam Strauss embarked on vigilante psychopharmacology.